FDA Approves Boston Scientific's Agent Drug-Coated Balloon for In-Stent Restenosis
Boston Scientific's Agent Drug-Coated Balloon (DCB) receives FDA approval for treating coronary in-stent restenosis, showing superior outcomes compared to conventional treatments.